BeOne Medicines AG
NASDAQONC reports its first-quarter 2026 results today — and the most telling signal heading in is not short positioning but the rapid accumulation of bullish analyst coverage on a stock that remains well below most price targets. The analyst setup is decidedly constructive. Wells Fargo initiated coverage just three days ago with an Overweight rating and a $400 target. Wolfe Research…
Snapshot as of 22 Jun 2026
ONC reports its first-quarter 2026 results today — and the most telling signal heading in is not short positioning but the rapid accumulation of bullish analyst coverage on a stock that remains well below most price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ONC — free to start on ORTEX.
Sign up for free →Open ONC on ORTEX